Predicting the survival benefit of liver transplantation in HBV-related acute-on-chronic liver failure: an observational cohort studyResearch in context

Predicting the survival benefit of liver transplantation in HBV-related acute-on-chronic liver failure: an observational cohort studyResearch in context

Summary: Background: Liver transplantation (LT) is an effective therapy for acute-on-chronic liver failure (ACLF) but is limited by organ shortages. We aimed to identify an appropriate score for predicting the survival benefit of LT in HBV-related ACLF patients. Methods: Hospitalized patients with...

Full description

Bibliographic Details
Main Authors: Peng Li, Xi Liang, Jinjin Luo, Jiaqi Li, Jiaojiao Xin, Jing Jiang, Dongyan Shi, Yingyan Lu, Hozeifa Mohamed Hassan, Qian Zhou, Shaorui Hao, Huafen Zhang, Tianzhou Wu, Tan Li, Heng Yao, Keke Ren, Beibei Guo, Xingping Zhou, Jiaxian Chen, Lulu He, Hui Yang, Wen Hu, Shiwen Ma, Bingqi Li, Shaoli You, Shaojie Xin, Yu Chen, Jun Li
Format: Article
Language:English
Published: Elsevier 2023-03-01
Series:The Lancet Regional Health. Western Pacific
Subjects:
Hepatitis B virus
Acute-on-chronic liver failure
Liver transplantation
Survival benefit
Transplant timing
Online Access:http://www.sciencedirect.com/science/article/pii/S266660652200253X

Internet

http://www.sciencedirect.com/science/article/pii/S266660652200253X

Similar Items